drugset / Trial / NCT00631696

Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo

NCT00631696

Phase 4 Completed 222 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindOther

Summary

This study is being performed as a Phase IV FDA commitment study and is being powered adequately to assess changes in sperm concentration, FSH and testosterone in healthy male subjects treated with pregabalin as compared to placebo, in addition to confirming lack of effects on sperm motility.

Timeline

Start
2008-02
Primary completion
2012-02
Completion
2012-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 600 mg

Indications

No indication recorded.